Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boehringer Ingelheim strikes Chinese production alliance

This article was originally published in Scrip

Executive Summary

Boehringer Ingelheimhas entered an alliance with the Chinese chemicals manufacturer Hisoarto supply pharmaceutical intermediates to the private German firm. Boehringer Ingelheim will incorporate these into active pharmaceutical ingredients for processing by its global production network. As part of the tie-up, Hisoar will invest in dedicated facilities at a new site in Chuannan which is scheduled to start early next year, and will receive know-how and technical support from its partner. The listed Chinese firm, based in Taizhou, Zhejiang province, had sales of around Yuan1 billion ($146.4 million) last year.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC003277

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel